The B (nondiabetogenic) and D (diabetogenic) variants of encephalomyocarditis (EMC) virus were studied to further define the role of the interferon (IFN) system in murine virus-induced diabetes mellitus. The relationship between the initial multiplicity of infection with EMC-B and the IFN yield showed that cells infected with one IFN-inducing particle produce a maximum amount of IFN, whereas IFN production is suppressed in cells infected with two or more particles. The IFN yield induced by EMC-D was less than 5% of that induced by EMC-B, allowing the designation of the B and D variants as Ifp+ and Ifp-, respectively. The Ifp+ property of the virion was shown to be responsible for the greater sensitivity of EMC-B to exogenous IFN as a result of primed local IFN induction. The data indicate that different Ifp phenotypes occur in nature and are associated with the development of diabetes in mice.
The M strain of encephalomyocarditis (EMC) virus causes a diabetes-like syndrome in susceptible mice which varies in incidence and severity with the passage history of the inoculum (1, 13). Yoon et al. (12) selected and plaque purified two variants of the M strain on the basis of their diabetogenic potential. The D variant spreads to and extensively involves the islets of Langerhans within 3 days after infection, resulting in diabetes in 95% of SJL mice. In contrast, antigens of the B variant are seen in some islet cells 3 days after infection, but the involvement is not extensive and diabetes does not occur. In addition, mice infected with EMC-B rapidly develop higher levels of circulating interferon (IFN) than do mice infected with EMC-D (12) . The observation that diabetes can be caused by EMC-B in mice given anti-IFN globulins or can be prevented with EMC-D in mice pretreated with IFN or IFN inducers constitutes further evidence that the IFN system is involved in the pathogenesis of virus-induced diabetes mellitus (11) .
After mutagenesis, a mengovirus mutant was isolated by Simon et al. (7) that appeared to be more sensitive to IFN action than the wild type.
Marcus et al. (5) showed that the IFN sensitivity of the mutant resulted from its ability to induce local IFN which amplified the effect of exogenous IFN. They demonstrated that the mutant virion acted as an IFN-inducing particle (IFP) and showed the relationship of the Ifp+ phenotype to IFN sensitivity and cell-sparing effects and that of the Ifp-phenotype to IFN insensivitity and cell destruction. To further define the role of the IFN system in virus-induced diabetes, we studied the sensitivity of the B and D variants to both exogenous and endogenous IFN. We present data indicating that EMC-B is phenotypically Ifp+ and that EMC-D is Ifp-.
MATERIALS AND METHODS
Cell cultures. Secondary mouse embryo (20 ME) fibroblast cultures were prepared by trypsinization of minced embryos. Cells were grown in Eagle minimal essential medium (MEM) supplemented with 10% calf serum (2% after monolayers were formed), penicillin (100 U/ml), and streptomycin (100 p.g/ml). (5) . Twenty hours later the medium was collected and processed for IFN assay.
In some experiments, polyinosinic acid-polycytidylic acid [poly(I-C)] with a minimum molecular weight of 100,000 (Sigma Chemical Co.) was used to sensitize L-cells for IFN induction (6, 8 ,ug/ml in 2 ml of phosphate-buffered saline for 2 h at 37°C. The poly(I-C) was removed, the cells were washed twice with MEM-2, and 3 ml of MEM-2 was added. After 18 h the medium was removed and assayed for IFN; no activity was present. The monolayers were then challenged with approximately 200 PFU of the B or D variant.
RESULTS

Inhibition of EMC-B and EMC-
After a 1-h adsorption period, plaques were allowed to form under 1.2% methylcellulose. After 48 h, the cells were fixed with ethanol and stained with 1% crystal violet. nitrous acid and selection for the property of IFN sensitivity (7), whereas the EMC variants described here were selected for their diabetogenic potential during.plaque purification (12) .
The Ifp+ phenotype controls several phenomena observed in infected cell cultures. First, it is clear that the observed IFN sensitivity is largely determined by the Ifp phenotype. This is evidenced by the greater IFN-induced inhibition of yield and plaque reduction that occurs when using IFN-treated (Fig. 3) . Nevertheless, this relatively small difference is sufficient to alter virus-induced cell destruction.
IFN-treated cells have an augmented response to IFN inducers such that "endogenous" IFN is produced earlier and in greater quantity than in untreated cells (2, 9) . This "priming" effect amplifies the expression of the Ifp+ phenotype.
It follows that the maximum difference between the two Ifp phenotypes will be observed in cultures (and conceivably in tissues) which have been preexposed to a low concentration of IFN sufficient to prime the cells for augmented IFN production but not sufficient to result in maximum antiviral resistance (Fig. 1) In conclusion, the EMC B and D variants can be designated Ifp+ and Ifp-, respectively. The in vitro phenomena related to the Ifp phenotype parallel in vivo findings in the murine diabetes model and provide evidence for the biological relevance of this property of the virion. c After the adsorption period, removal of the inoculum, and washing of the cells, 3 ml of medium containing 50 ,ug of cycloheximide or 5 ,ug of actinomycin D per ml was added.
d EMC-B was allowed to react with antiserum for 30 min at 37°C before inoculation.
